TY - JOUR
T1 - Hidden depression in otolaryngology patients with medically unexplained symptoms
AU - Goto, Fumiyuki
AU - Tsutsumi, Tomoko
AU - Oishi, Naoki
AU - Mimura, Masaru
N1 - Funding Information:
Part of this study was supported by the grant from The Mental Health Okamoto Memorial Foundation (2011).
PY - 2012/3
Y1 - 2012/3
N2 - Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.
AB - Objective: To investigate the prevalence of depression among otolaryngology patients with medically unexplained symptoms (MUS) and the outcome of treatment with selective serotonin reuptake inhibitors (SSRIs). Method: Ninety patients with MUS from a population of 983 consecutive otolaryngology outpatients were enrolled. The Self-Rating Depression Scale (SDS) was used to screen for depression. In addition to standard treatment, all depressed and nondepressed patients received SSRIs for 8 weeks. The Clinical Global Impression-Improvement (CGI-I) scale was used to evaluate clinical changes in patients with MUS. Results: There were 49 patients with depression among those with MUS, according to the SDS criteria. The patients with depression showed a better outcome than those without depression, demonstrating more significantly improved CGI-I scores. Conclusion: More than half of the individuals with otolaryngological MUS had depression, and their MUS were successfully treated withSSRIs.
KW - Antidepressant
KW - Depression
KW - Medically unexplained symptoms
KW - Selective serotonin reuptake inhibitors
UR - http://www.scopus.com/inward/record.url?scp=84857361869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857361869&partnerID=8YFLogxK
U2 - 10.1016/j.genhosppsych.2011.09.014
DO - 10.1016/j.genhosppsych.2011.09.014
M3 - Article
C2 - 22055330
AN - SCOPUS:84857361869
SN - 0163-8343
VL - 34
SP - 206
EP - 208
JO - General Hospital Psychiatry
JF - General Hospital Psychiatry
IS - 2
ER -
